| Patent | Date |
|---|
Orally Administrable Modified-release Pharmaceutical Dosage Form
App 20220257547 - Stroyer; Anke ; et al. | 2022-08-18 |
Orally administrable modified-release pharmaceutical dosage form
Grant 11,344,519 - Stroyer , et al. May 31, 2 | 2022-05-31 |
The Atr Kinase Inhibitor Bay1895344 For Use In The Treatment Of A Hyper-proliferative Disease
App 20220117973 - KRICKAU; Dennis ; et al. | 2022-04-21 |
Pharmaceutical Dosage Form Which Can Be Administered Orally And Has Modified Release
App 20210283046 - Stroyer; Anke ; et al. | 2021-09-16 |
Orally Administrable Modified-release Pharmaceutical Dosage Form
App 20210113504 - Stroyer; Anke ; et al. | 2021-04-22 |
Orally administrable modified-release pharmaceutical dosage form
Grant 10,905,667 - Stroyer , et al. February 2, 2 | 2021-02-02 |
Orally Administrable Modified-released Pharmaceutical Dosage Form
App 20200237648 - STROYER; ANKE ; et al. | 2020-07-30 |
Orally Administrable Modified-release Pharmaceutical Dosage Form
App 20200030270 - Stroyer; Anke ; et al. | 2020-01-30 |
Pharmaceutical composition and the use thereof, and application regime of said pharmaceutical composition for on-demand contraception
Grant 9,655,887 - Lindenthal , et al. May 23, 2 | 2017-05-23 |
Use and application regimen of a pharmaceutical composition containing levonorgestrel and a COX inhibitor for on-demand contraception
Grant 9,579,330 - Lindenthal , et al. February 28, 2 | 2017-02-28 |
Pharmaceutical Composition And The Use Thereof, And Application Regime Of Said Pharmaceutical Composition For On-demand Contraception
App 20160089364 - LlNDENTHAL; Bernhard ; et al. | 2016-03-31 |
Use And Application Regimen Of A Pharmaceutical Composition Containing Levonorgestrel And A Cox Inhibitor For On-demand Contraception
App 20160000805 - LINDENTHAL; Bernhard ; et al. | 2016-01-07 |
Medicaments containing vardenafil hydrochloride trihydrate
Grant 8,841,446 - Serno , et al. September 23, 2 | 2014-09-23 |
Drug Formulations Having Improved Pharmacokinetic Properties
App 20140186444 - Serno; Peter ; et al. | 2014-07-03 |
Pharmaceutical forms with improved pharmacokinetic properties
Grant 8,613,950 - Serno , et al. December 24, 2 | 2013-12-24 |
Medicaments Containing Vardenafil Hydrochloride Trihydrate
App 20130078306 - Serno; Peter ; et al. | 2013-03-28 |
2-phenyl Substituted Imidazotriazinones As Phosphodiesterase Inhibitors
App 20130059844 - Niewohner; Ulrich ; et al. | 2013-03-07 |
Medicaments containing vardenafil hydrochloride trihydrate
Grant 8,273,876 - Serno , et al. September 25, 2 | 2012-09-25 |
2-phenyl Substituted Imidazotriazinones As Phosphodiesterase Inhibitors
App 20110009367 - Niewohner; Ulrich ; et al. | 2011-01-13 |
2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
Grant 7,704,999 - Niewohner , et al. April 27, 2 | 2010-04-27 |
2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
Grant 7,696,206 - Niewohner , et al. April 13, 2 | 2010-04-13 |
2-phenyl Substituted Imidazotriazinones As Phosphodiesterase Inhibitors
App 20100016323 - Niewohner; Ulrich ; et al. | 2010-01-21 |
Uses of 2-Phenyl-Substituted Imidazotriazinone Derivatives for Treating Pulmonary Hypertension
App 20090221570 - Haning; Helmut ; et al. | 2009-09-03 |
Drug Forms Having Controlled Bioavailability
App 20090017122 - Serno; Peter ; et al. | 2009-01-15 |
Intravenous Formulations of Pde Inhibitors
App 20080280914 - Serno; Peter ; et al. | 2008-11-13 |
Formulations with Controlled Release of Active Ingredient
App 20080268046 - Zuleger; Susanne ; et al. | 2008-10-30 |
Pharmaceutical Forms with Improved Pharmacokinetic Properties
App 20080249096 - Serno; Peter ; et al. | 2008-10-09 |
Formulations With Controlled Release Of Active Ingredient
App 20080187588 - Zuleger; Susanne ; et al. | 2008-08-07 |
2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
App 20080113972 - Niewohner; Ulrich ; et al. | 2008-05-15 |
2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors, for treatment of hypertension
Grant 7,314,871 - Niewohner, legal representative , et al. January | 2008-01-01 |
2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
App 20060189615 - Niewohner; Ulrich ; et al. | 2006-08-24 |
Medicaments containing vardenafil hydrochloride trihydrate
App 20060111354 - Serno; Peter ; et al. | 2006-05-25 |
2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
Grant 6,890,922 - Niewohner , et al. May 10, 2 | 2005-05-10 |
2-Phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
App 20050070541 - Niewohner, Ulrich ; et al. | 2005-03-31 |
Imidazotriazinone-containing compositions for nasal administration
App 20040248891 - Serno, Peter ; et al. | 2004-12-09 |
Compositions for nasal application
App 20040142944 - Serno, Peter ; et al. | 2004-07-22 |
Imidazotriazinone-containing compositions for nasal administration
Grant 6,740,306 - Serno , et al. May 25, 2 | 2004-05-25 |
2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
App 20040067945 - Niewohner, Ulrich ; et al. | 2004-04-08 |
2-phenyl substituted imidatriazinones as phosphodiesterase inhibitors
Grant 6,566,360 - Niewohner , et al. May 20, 2 | 2003-05-20 |
Imidazotriazinone-containing compositions for nasal administration
App 20030022894 - Serno, Peter ; et al. | 2003-01-30 |
2-phenyl substituted imidazotriazinones as phosphodiesterase inhibitors
Grant 6,362,178 - Niewohner , et al. March 26, 2 | 2002-03-26 |
Process for the preparation of medicament formulations with controlled release
Grant 5,707,655 - Kanikanti , et al. January 13, 1 | 1998-01-13 |
Injectable liposomal pharmaceutical preparations
Grant 5,653,998 - Hamann , et al. August 5, 1 | 1997-08-05 |
Infusion solutions of 1-cyclopropyl-6-fluoro-1,4-di-hydro-4-oxo-7-(1-piperazinyl)-quinoline-3- carboxylic acid
Grant 4,957,922 - Lammens , et al. September 18, 1 | 1990-09-18 |
Medicament formulation
Grant 4,711,902 - Serno December 8, 1 | 1987-12-08 |
| 